跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000 MCG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000 MCG/ML
Approved
THERAPEUTIC
ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000 MCG/ML
Alcami Carolinas Corporation
🇸🇬 Health Sciences Authority
Approval Date
Aug 5, 2024
Approval ID
6d3f79e10e33c0a9
Company
Alcami Carolinas Corporation
Type
Therapeutic
Approval Details
Approval Id
6d3f79e10e33c0a9
Drug Name
ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000 MCG/ML
Product Name
ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000 MCG/ML
Approval Number
SIN17059P
Approval Date
2024-08-05
Registrant
A. MENARINI SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01XX67
Pharma Manufacturer Name
A. MENARINI SINGAPORE PTE. LTD.
Company Detail Path
/organization/a-menarini-singapore-pte-ltd
Active Ingredients
TAGRAXOFUSP
1.0 MG/mL
TAGRAXOFUSP
1.0 MG/mL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 5, 2024
Approval ID
6d3f79e10e33c0a9
Type
Therapeutic
Back to HSA Approvals
